Trader Note — 10198 total
DIS reported Q2 2026 earnings this morning with results that, on paper, were genuinely strong — and yet the stock ended the day down nearly 1%, sitting at $100.48. That gap between a solid print and a muted price…
DENTSPLY SIRONA emerged from its Q1 results this week with a mixed scorecard — a top-line beat offset by a slim EPS miss — and a short base that, despite trimming slightly, remains near its highest level in a…
DECK heads into its May 21 earnings with a fresh analyst upgrade arriving almost precisely as the stock suffers its worst weekly drop in months — and the market's reaction so far has been to lean bullish rather than…
DaVita enters the week after earnings on a completely different footing than it started — a Deutsche Bank upgrade to Buy with a $220 target has reset the debate on a stock that most of the Street had treated as dead…
CMI enters its May 12 Q1 earnings call with a rare alignment: the stock is up 23% in a month, the Street is scrambling to lift targets, and the borrow market is one of the loosest in the industrial universe. The setup…
GLW enters the new week with a fresh tailwind — the stock has risen 6% in the past week and nearly 10% over the past month, sitting at $162.10 after a strong earnings-driven reaction that prompted a wave of analyst…
Ingredion Incorporated heads into its May 20 earnings date with options traders suddenly far more defensive than they have been all year. The sharpest signal this week is in the options market. The put/call ratio…
Consumer Portfolio Services heads into the post-earnings session with a clear split: revenue came in ahead of expectations, but the bottom line disappointed — and the stock had already priced in a lot of good news…
CTSH enters the post-earnings week under broad analyst pressure, with nearly every major firm trimming its price target while keeping ratings in place — a pattern that signals diminished confidence rather than outright…
CCOI is trading at $18.06 after one of its worst weeks in recent memory — a 25% collapse driven by a Q1 earnings report that sent the stock down 22% in a single session. The catalyst was May 4's Q1 2026 results.…
Clean Harbors heads into the week after its May 6 earnings release with the stock up 2.5% on the week, shorts in retreat, and a string of analyst upgrades that began well before the print. The most compelling story…
CVX heads into its May 27 Q1 results with the Street turning more constructive — but the stock's own insiders were quietly selling into that optimism earlier this spring. The analyst picture has shifted meaningfully in…
Cardinal Health heads into the first full week of May under pressure, having shed 4.2% over the past week to close at $197, while the Street digests a mixed earnings signal and a wave of freshly cut price targets. The…
CBT reported Q2 fiscal 2026 results on May 5 that beat on every line — yet short sellers used the rally to add, not reduce. That tension sits at the heart of this week's setup. Cabot's headline numbers were clean.…
CVS Health heads into its May 14 earnings call with short sellers meaningfully rebuilding positions after a multi-week retreat — the most notable repositioning on the stock this side of April. The short-interest story…
Bruker Corporation heads into the post-earnings session with a clean beat and short sellers on the back foot — the sharpest tension of the week is between a positioning structure that expected more pain and a print…
Azenta enters the post-earnings week with one of the sharpest short-interest buildups in its recent history — and the stock has barely flinched. Short sellers have been piling into AZTA at a pace that stands out even…
Boston Scientific has spent the past two weeks being repriced lower — down 11% in a month and touching a fresh 52-week low — and the central question now is whether that rerating is a correction or the start of…
SAM enters May with a compound problem: a stock down 13% in a month, options traders at near-peak defensive positioning, and every analyst on the Street still holding neutral but trimming targets in the wake of a…
BorgWarner reported Q1 2026 results today that landed cleanly ahead of estimates — and the options market had already begun pricing in a friendlier outcome. The most striking data point this week is not in the short…
